Aptis, a subsidiary of Dong-A ST, said on the 27th that it signed a business agreement with Cops Bio for joint research on a new antibody–degrader conjugate (DAC) drug. An antibody–drug conjugate (ADC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback